| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99241 |
|
631 |
537 |
$62K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
744 |
671 |
$43K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
375 |
341 |
$24K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
141 |
138 |
$10K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
237 |
207 |
$9K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
179 |
166 |
$8K |
| 99215 |
Prolong outpt/office vis |
94 |
79 |
$8K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
140 |
140 |
$5K |
| S9083 |
Global fee urgent care centers |
12 |
12 |
$2K |
| 99242 |
|
12 |
12 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
105 |
78 |
$1K |
| 90715 |
|
28 |
26 |
$888.76 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
12 |
12 |
$392.16 |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
13 |
12 |
$314.60 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
19 |
19 |
$298.30 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
81 |
81 |
$287.44 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
151 |
139 |
$165.52 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
12 |
12 |
$143.50 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
31 |
31 |
$137.40 |